protein kinase inhibitors

Preferred Label : protein kinase inhibitors;

MeSH definition : Agents that inhibit PROTEIN KINASES.;

MeSH synonym : inhibitors, protein kinase; kinase inhibitors, protein; Protein Kinase Inhibitor; Inhibitor, Protein Kinase; Kinase Inhibitor, Protein;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D047428;

UMLS CUI

C1449702;

ATC code(s)
- Anaplastic lymphoma kinase (ALK) inhibitors [ATC Code]
- B-Raf serine-threonine kinase (BRAF) inhibitors [ATC Code]
- BCR-ABL tyrosine kinase inhibitors [ATC Code]
- Bruton's tyrosine kinase (BTK) inhibitors [ATC Code]
- Cyclin-dependent kinase (CDK) inhibitors [ATC Code]
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors [ATC Code]
- Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors [ATC Code]
- Mitogen-activated protein kinase (MEK) inhibitors [ATC Code]
- PROTEIN KINASE INHIBITORS [ATC Code]
- Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Inupiaq Language [NCIt concept]
- PROTEIN KINASE INHIBITORS [ATC Code]
- Protein Kinase A Inhibitor [NCIt concept]
- Protein kinase inhibitor (disposition) [SNOMED CT concept]
- Protein kinase inhibitors [ICD-11 Extension code]
CISMeF manual mappings
- Substance with protein kinase inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Product containing protein kinase inhibitor (product) [SNOMED CT concept]
- Protein Kinase Inhibitor [NCIt concept]
Indexing information
- (4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone [MeSH Supplementary Concept]
- 1-(2-(1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-1,3-benzodiazol-6-yl)ethynyl)cyclohexan-1-ol [MeSH Supplementary Concept]
- 1-(4-(2-((6-(4-(2-(dimethylamino)ethoxy)phenyl)furo(2,3-d)pyrimidin-4-yl)amino)ethyl)phenyl)-3-phenylurea [MeSH Supplementary Concept]
- 1-(6-(3,5-dichloro-4-hydroxyphenyl)-4-((4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)ethanone [MeSH Supplementary Concept]
- 1-benzyl-N-(2,4-dichlorobenzyl)-1H-indole-2-carboxamide [MeSH Supplementary Concept]
- 1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea [MeSH Supplementary Concept]
- 1NMPP1 compound [MeSH Supplementary Concept]
- 2-((2,4-dihydroxyphenyl)sulfonyl)isoindoline-4,6-diol [MeSH Supplementary Concept]
- 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate [MeSH Supplementary Concept]
- 2-((4-aminocyclohexyl)amino)-4-((3-(trifluoromethyl)phenyl)amino)pyrido(4,3-d)pyrimidin-5(6H)-one [MeSH Supplementary Concept]
- 2-(3-cyano-6-methoxyquinolin-2-ylthio)-N-(2-methoxy-5-methylphenyl)acetamide [MeSH Supplementary Concept]
- 2-(3-oxo-1-phenyl-3-(4-(trifluoromethyl)phenyl)propyl)malonic acid [MeSH Supplementary Concept]
- 2-(4-(3-chloro-5-fluoro-6-(1H-pyrazolo(3,4-b)pyridin-3-yl)pyridin-2-yl)piperazin-2-yl)-3-methylbutan-2-ol [MeSH Supplementary Concept]
- 2-(4-chlorobenzylsulfonyl)-3-(4-nitrophenyl)-1-phenylprop-2-en-1-one [MeSH Supplementary Concept]
- 2-(4-morpholinoanilino)-6-cyclohexylaminopurine [MeSH Supplementary Concept]
- 2-isobutyl-3-oxo-4-chloro-2-butylcarbonate [MeSH Supplementary Concept]
- 2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile [MeSH Supplementary Concept]
- 3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo(4,5-b)pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole [MeSH Supplementary Concept]
- 3-(2-aminoethyl)-5-(3-(4-butoxylphenyl)propylidene)thiazolidine-2,4-dione [MeSH Supplementary Concept]
- 3-isomangostin [MeSH Supplementary Concept]
- 4-(3-chloro-2-fluorophenoxy)-1-((6-(1,3-thiazol-2-ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acid [MeSH Supplementary Concept]
- 4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline [MeSH Supplementary Concept]
- 4-(4-(trifluoromethyl)phenyl)-N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 4-methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine [MeSH Supplementary Concept]
- 4-methyl-5-(4-pyridinyl)-2(3H)-oxazolone [MeSH Supplementary Concept]
- 5-amino-1-(1-cyanopiperidin-3-yl)-3-(4-(2,4-difluorophenoxy)phenyl)-1H-pyrazole-4-carboxamide [MeSH Supplementary Concept]
- 5-amino-4-(1,3-benzothiazol-2-yl)-1-(3-methoxyphenyl)-1,2-dihydro-3H-pyrrol-3-one [MeSH Supplementary Concept]
- 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 8-ethyl-2,5,6,12-tetrahydro-3,10,10-trimethyl-9-oxopyrazolo(4',3'-6,7)cyclohepta(1,2-b)pyrrolo(2,3-f)indole [MeSH Supplementary Concept]
- 9-phenanthrol [MeSH Supplementary Concept]
- AZ191 compound [MeSH Supplementary Concept]
- AZD1208 [MeSH Supplementary Concept]
- AZD8330 [MeSH Supplementary Concept]
- BPR1K653 [MeSH Supplementary Concept]
- CC214-2 [MeSH Supplementary Concept]
- CCT129202 [MeSH Supplementary Concept]
- CEP-28122 [MeSH Supplementary Concept]
- CP-654577 [MeSH Supplementary Concept]
- CTx-0294885 [MeSH Supplementary Concept]
- Camk2n1 protein, rat [MeSH Supplementary Concept]
- ENMD 2076 [MeSH Supplementary Concept]
- FAK peptide [MeSH Supplementary Concept]
- G6 stilbenoid tyrosine kinase inhibitor [MeSH Supplementary Concept]
- GSK 1070916 [MeSH Supplementary Concept]
- HA 1100 [MeSH Supplementary Concept]
- HTH-01-015 [MeSH Supplementary Concept]
- IP 20 [MeSH Supplementary Concept]
- KN 04 [MeSH Supplementary Concept]
- KU-0068650 [MeSH Supplementary Concept]
- KW 2449 [MeSH Supplementary Concept]
- LY2603618 [MeSH Supplementary Concept]
- MLN 8237 [MeSH Supplementary Concept]
- MLN8054 [MeSH Supplementary Concept]
- N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide [MeSH Supplementary Concept]
- N-(2,6-diethylphenyl)-1-methyl-8-((4-((1-methylpiperidin-4-yl)carbamoyl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide [MeSH Supplementary Concept]
- N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide [MeSH Supplementary Concept]
- N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- N-(3-(4-benzamido-1H-pyrrolo(3,2-c)pyridin-1-yl)phenyl)-4-morpholino-3-(trifluoromethyl)benzamide [MeSH Supplementary Concept]
- N-(3-fluoro-4-(6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinolin-4-yloxy)phenyl)-4-oxo-1-(2-(trifluoromethyl)phenyl)-1,4-dihydrocinnoline-3-carboxamide [MeSH Supplementary Concept]
- N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine [MeSH Supplementary Concept]
- N-3-(1H-indol-5-yl)-5-pyridin-4-yl-pyrazine-2,3-diamine [MeSH Supplementary Concept]
- N1-(3-fluoro-4-(6-methoxy-7-(3-(4-methylpiperidin-1-yl)propoxy)quinolin-4-yloxy)phenyl)-N4-(2,4-difluorobenzylidene)semicarbazide [MeSH Supplementary Concept]
- N2-(5-chloro-1-(3-fluoro-1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-4-yl)-N4-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine [MeSH Supplementary Concept]
- NA 0344 [MeSH Supplementary Concept]
- OM 137 [MeSH Supplementary Concept]
- OSI-296 [MeSH Supplementary Concept]
- OXVW5 compound [MeSH Supplementary Concept]
- PF-00562271 [MeSH Supplementary Concept]
- PHA 680626 [MeSH Supplementary Concept]
- PHA 680632 [MeSH Supplementary Concept]
- R1498 compound [MeSH Supplementary Concept]
- RO5126766 [MeSH Supplementary Concept]
- Ro5203280 [MeSH Supplementary Concept]
- SNS 314 [MeSH Supplementary Concept]
- TAK-632 [MeSH Supplementary Concept]
- TAK-901 [MeSH Supplementary Concept]
- UNC2250 [MeSH Supplementary Concept]
- UNC2881 [MeSH Supplementary Concept]
- URMC-099 [MeSH Supplementary Concept]
- WZ4003 [MeSH Supplementary Concept]
- YARA peptide [MeSH Supplementary Concept]
- alectinib [MeSH Supplementary Concept]
- bafetinib [MeSH Supplementary Concept]
- brevilin A [MeSH Supplementary Concept]
- danusertib [MeSH Supplementary Concept]
- doramapimod [MeSH Supplementary Concept]
- flumatinib [MeSH Supplementary Concept]
- indirubin [MeSH Supplementary Concept]
- jadomycin B [MeSH Supplementary Concept]
- kb-NB142-70 [MeSH Supplementary Concept]
- kb-NB165-09 [MeSH Supplementary Concept]
- lestaurtinib [MeSH Supplementary Concept]
- mangostin [MeSH Supplementary Concept]
- masitinib [MeSH Supplementary Concept]
- merestinib [MeSH Supplementary Concept]
- simalikalactone E [MeSH Supplementary Concept]
- spebrutinib [MeSH Supplementary Concept]
- temsirolimus [MeSH Supplementary Concept]
- tozasertib [MeSH Supplementary Concept]
- vistusertib [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- protein kinases [MeSH Descriptor]
Record concept(s)
- protein kinase inhibitors [MeSH concept]
See also (suggested by CISMeF)
- protein kinases [MeSH Descriptor]
See also inter- (CISMeF)
- senolytic [SYNODOS term]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide [MeSH Supplementary Concept]
- (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide [MeSH Supplementary Concept]
- 1,2,4-triazolo-(3,4-b)-1,3,4-thiadiazoles [MeSH Supplementary Concept]
- 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine [MeSH Supplementary Concept]
- 2 (4'-hydroxynaphthyl) chromen-4-one [MeSH Supplementary Concept]
- 2-((3-acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide [MeSH Supplementary Concept]
- 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide [MeSH Supplementary Concept]
- 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide [MeSH Supplementary Concept]
- 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one [MeSH Supplementary Concept]
- 3,4-diaminonaphthalene-2,7-disulfonic acid [MeSH Supplementary Concept]
- 4,5-dianilinophthalimide [MeSH Supplementary Concept]
- 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide [MeSH Supplementary Concept]
- 4-(2,3-dihydro-1H-benzo(d)pyrrolo(1,2-a)imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine [MeSH Supplementary Concept]
- 4-ethoxy-7H-pyrrolo(2,3-d)pyrimidin-2-amine [MeSH Supplementary Concept]
- 6,7-dimethoxy-4-anilinoquinoline [MeSH Supplementary Concept]
- 7-hydroxystaurosporine [MeSH Supplementary Concept]
- 8-((3-bromophenyl)amino)-3-methyl-3H-imidazo(4,5-g)quinazoline [MeSH Supplementary Concept]
- 9-phenanthrol [MeSH Supplementary Concept]
- A-484954 [MeSH Supplementary Concept]
- A131 compound [MeSH Supplementary Concept]
- AL622 [MeSH Supplementary Concept]
- AZ31 compound [MeSH Supplementary Concept]
- AZ5104 [MeSH Supplementary Concept]
- AZD-0424 [MeSH Supplementary Concept]
- AZD0156 [MeSH Supplementary Concept]
- AZD7624 [MeSH Supplementary Concept]
- AZD7648 [MeSH Supplementary Concept]
- Afatinib [MeSH Descriptor]
- Axitinib [MeSH Descriptor]
- BKI1 protein, arabidopsis [MeSH Supplementary Concept]
- CAM187 [MeSH Supplementary Concept]
- CGP 77675 [MeSH Supplementary Concept]
- CHMFL-FLT3-213 compound [MeSH Supplementary Concept]
- CL 387785 [MeSH Supplementary Concept]
- CL27c [MeSH Supplementary Concept]
- Crizotinib [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p15 [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p18 [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p19 [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p21 [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p27 [MeSH Descriptor]
- Cyclin-Dependent kinase inhibitor p57 [MeSH Descriptor]
- Dasatinib [MeSH Descriptor]
- Debio 0617B [MeSH Supplementary Concept]
- EGFR tyrosine kinase inhibitor 324674 [MeSH Supplementary Concept]
- EKB 569 [MeSH Supplementary Concept]
- Erlotinib Hydrochloride [MeSH Descriptor]
- FF-10101 [MeSH Supplementary Concept]
- GADD45beta-I [MeSH Supplementary Concept]
- GDC-0575 [MeSH Supplementary Concept]
- GNE-924 [MeSH Supplementary Concept]
- GS-680 [MeSH Supplementary Concept]
- GSK2636771 [MeSH Supplementary Concept]
- GSK2646264 [MeSH Supplementary Concept]
- GSK3186899 [MeSH Supplementary Concept]
- Gefitinib [MeSH Descriptor]
- IBL-302 [MeSH Supplementary Concept]
- INCB 54828-101 [MeSH Supplementary Concept]
- IkK-16 compound [MeSH Supplementary Concept]
- Imatinib Mesylate [MeSH Descriptor]
- JH-VIII-157-02 [MeSH Supplementary Concept]
- JNK-IN-8 [MeSH Supplementary Concept]
- JTE-952 [MeSH Supplementary Concept]
- KAN0439834 [MeSH Supplementary Concept]
- KIRA6 [MeSH Supplementary Concept]
- KN 93 [MeSH Supplementary Concept]
- KRP4 protein, arabidopsis [MeSH Supplementary Concept]
- KT 5823 [MeSH Supplementary Concept]
- KX2-361 [MeSH Supplementary Concept]
- LIMKi3 [MeSH Supplementary Concept]
- LN950 [MeSH Supplementary Concept]
- Lapatinib [MeSH Descriptor]
- MP 412 [MeSH Supplementary Concept]
- N(6),N(6)-dimethyladenine [MeSH Supplementary Concept]
- N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide [MeSH Supplementary Concept]
- N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide [MeSH Supplementary Concept]
- N-(2-aminoethyl)-5-isoquinolinesulfonamide [MeSH Supplementary Concept]
- N-(2-guanidinoethyl)-5-isoquinolinesulfonamide [MeSH Supplementary Concept]
- N-(4-methyl-3-(1-methyl-7-(6-methylpyridin-3-ylamino)-2-oxo-1,2-dihydropyrimido(4,5-d)pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide [MeSH Supplementary Concept]
- N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide [MeSH Supplementary Concept]
- N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide [MeSH Supplementary Concept]
- NTRC 0066-0 [MeSH Supplementary Concept]
- Nemiralisib [MeSH Supplementary Concept]
- ON 01910 [MeSH Supplementary Concept]
- ONO-7579 [MeSH Supplementary Concept]
- OTS167 [MeSH Supplementary Concept]
- PD 166866 [MeSH Supplementary Concept]
- PD 180970 [MeSH Supplementary Concept]
- PF 00477736 [MeSH Supplementary Concept]
- PF-04802367 [MeSH Supplementary Concept]
- PF-06700841 [MeSH Supplementary Concept]
- PF-5236216 [MeSH Supplementary Concept]
- PF-670462 [MeSH Supplementary Concept]
- PFE-360 [MeSH Supplementary Concept]
- PKI 166 [MeSH Supplementary Concept]
- R333 [MeSH Supplementary Concept]
- RapaLink-1 [MeSH Supplementary Concept]
- Roscovitine [MeSH Descriptor]
- SB 239063 [MeSH Supplementary Concept]
- SHC004-221A1 [MeSH Supplementary Concept]
- Sorafenib [MeSH Descriptor]
- Sunitinib [MeSH Descriptor]
- TAK1 inhibitor NG25 [MeSH Supplementary Concept]
- TAS-121 [MeSH Supplementary Concept]
- TKM-080301 [MeSH Supplementary Concept]
- UM-164 [MeSH Supplementary Concept]
- Vemurafenib [MeSH Descriptor]
- WZ4002 [MeSH Supplementary Concept]
- Wortmannin [MeSH Descriptor]
- X480 [MeSH Supplementary Concept]
- XL647 [MeSH Supplementary Concept]
- YKL-05-099 [MeSH Supplementary Concept]
- YKL-5-124 [MeSH Supplementary Concept]
- abivertinib [MeSH Supplementary Concept]
- abrocitinib [MeSH Supplementary Concept]
- acalabrutinib [MeSH Supplementary Concept]
- acrizanib [MeSH Supplementary Concept]
- acumapimod [MeSH Supplementary Concept]
- adenosine-3',5'-cyclic phosphorothioate [MeSH Supplementary Concept]
- aflutinib [MeSH Supplementary Concept]
- agerafenib [MeSH Supplementary Concept]
- alvocidib [MeSH Supplementary Concept]
- apatinib [MeSH Supplementary Concept]
- bafetinib [MeSH Supplementary Concept]
- belizatinib [MeSH Supplementary Concept]
- belumosudil [MeSH Supplementary Concept]
- branebrutinib [MeSH Supplementary Concept]
- butyrolactone I [MeSH Supplementary Concept]
- calphostin D [MeSH Supplementary Concept]
- cediranib [MeSH Supplementary Concept]
- ceritinib [MeSH Supplementary Concept]
- chiauranib [MeSH Supplementary Concept]
- conteltinib [MeSH Supplementary Concept]
- cyclin-dependent kinase inhibitor proteins [MeSH Descriptor]
- dabrafenib [MeSH Supplementary Concept]
- deucravacitinib [MeSH Supplementary Concept]
- dorsomorphin [MeSH Supplementary Concept]
- emodin [MeSH Descriptor]
- ensartinib [MeSH Supplementary Concept]
- entrectinib [MeSH Supplementary Concept]
- fasudil [MeSH Supplementary Concept]
- flumatinib [MeSH Supplementary Concept]
- gedatolisib [MeSH Supplementary Concept]
- genistein [MeSH Descriptor]
- hesperadin [MeSH Supplementary Concept]
- ilorasertib [MeSH Supplementary Concept]
- ipatasertib [MeSH Supplementary Concept]
- lazertinib [MeSH Supplementary Concept]
- lenvatinib [MeSH Supplementary Concept]
- midostaurin [MeSH Supplementary Concept]
- motesanib diphosphate [MeSH Supplementary Concept]
- naquotinib [MeSH Supplementary Concept]
- nintedanib [MeSH Supplementary Concept]
- onvansertib [MeSH Supplementary Concept]
- orantinib [MeSH Supplementary Concept]
- osimertinib [MeSH Supplementary Concept]
- palbociclib [MeSH Supplementary Concept]
- peposertib [MeSH Supplementary Concept]
- phosphatidylethanolamine binding protein [MeSH Descriptor]
- pkia protein, mouse [MeSH Supplementary Concept]
- pkia protein, rat [MeSH Supplementary Concept]
- pkig protein, mouse [MeSH Supplementary Concept]
- ponatinib [MeSH Supplementary Concept]
- prexasertib [MeSH Supplementary Concept]
- protein kinase inhibitor M (6-24) [MeSH Supplementary Concept]
- protein kinase inhibitor peptide [MeSH Supplementary Concept]
- protein kinase inhibitor peptide (1-31) [MeSH Supplementary Concept]
- protein kinase inhibitor peptide (5-24) [MeSH Supplementary Concept]
- protein kinase inhibitor peptide (6-24) [MeSH Supplementary Concept]
- ravoxertinib [MeSH Supplementary Concept]
- rebastinib [MeSH Supplementary Concept]
- rimacalib [MeSH Supplementary Concept]
- selonsertib [MeSH Supplementary Concept]
- semaxinib [MeSH Supplementary Concept]
- senexin A [MeSH Supplementary Concept]
- spebrutinib [MeSH Supplementary Concept]
- trametinib [MeSH Supplementary Concept]
- tryptanthrin-6-oxime [MeSH Supplementary Concept]
- tucatinib [MeSH Supplementary Concept]
- vactosertib [MeSH Supplementary Concept]
- vatalanib [MeSH Supplementary Concept]
- vorolanib [MeSH Supplementary Concept]
- voruciclib [MeSH Supplementary Concept]
- zanubrutinib [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing protein kinase inhibitor (product) [SNOMED CT concept]
- Protein Kinase Inhibitor [NCIt concept]
- Substance with protein kinase inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients